netFormulary Isle of Wight NHS
Formulary  
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:

Chemotherapy drugs are frequently given in combination.

Disease specific protocols are approved at local and network level.

Only approved protocols should be used. All chemotherapy treatment decisions should be made by a consultant grade oncologist or haematologist, with input from the relevant multidisciplinary team. 

 Chemotherapy drugs, including oral therapies must be prescribed, dispensed and administered only by suitably trained staff. 

Paediatric cancer therapies are initiated and prescribed from tertiary cancer centres. The exception is maintenance treatment for some cancers, which is prescribed by designated paediatricians only.

Cancer Drugs Fund (CDF) - Drug List

 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
Drugs for cytotoxic-induced side-effects (2,0)
08.01.01 Alkylating drugs (6,0)
08.01.02 Anthracyclines and other cytotoxic antibiotics (6,0)
08.01.03 Antimetabolites (10,0)
08.01.04 Vinca alkaloids and etoposide (4,0)
08.01.05 Other antineoplastic drugs (10,0)
Bevacizumab (1,0)
Bortezomib (1,0)
Brentuximab vedotin (1,0)
Cetuximab (1,0)
Dacarbazine and Temozolomide (1,0)
Hydroxycarbamide (1,0)
Imatinab (0,0)
Panitumumab (0,0)
Platinum compounds (3,0)
Protein kinase inhibitors (8,0)
Taxanes (3,0)
Topoisomerase I inhibitors (2,0)
Trastuzumab (1,0)
Immunosuppressant therapy (0,0)
08.02.03 Anti-lymphocyte monoclonal antibodies (1,0)
08.02.04 Other immunomodulating drugs (5,0)
Interferon Alfa (1,0)
Interferon beta (1,0)
Interferon gamma (0,0)
BCG bladder instillation (0,0)
Canakinumab (0,0)
Dimethyl fumarate (0,0)
Fingolimod (0,0)
Histamine (0,0)
Lenalidomide, pomalidomide, and thalidomide (0,0)
Teriflunomide (0,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (1,0)
08.03.02 Progestogens (1,0)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (6,0)
Gonadorelin analogues (1,0)
Anti-androgens (8,0)
08.03.04.03 Somatostatin analogues (4,0)
netFormulary